SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-066564
Filing Date
2012-12-05
Accepted
2012-12-05 16:25:46
Documents
12
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v329502_10q.htm 10-Q 377213
2 EXHIBIT 10.1 v329502_ex10-1.htm EX-10.1 162635
3 EXHIBIT 31.1 v329502_ex31-1.htm EX-31.1 7475
4 EXHIBIT 31.2 v329502_ex31-2.htm EX-31.2 7779
5 EXHIBIT 32.1 v329502_ex32-1.htm EX-32.1 3997
6 EXHIBIT 32.2 v329502_ex32-2.htm EX-32.2 4347
  Complete submission text file 0001144204-12-066564.txt   4737640

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mrna-20120930.xml EX-101.INS 529175
8 XBRL TAXONOMY EXTENSION SCHEMA mrna-20120930.xsd EX-101.SCH 66502
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mrna-20120930_cal.xml EX-101.CAL 39224
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrna-20120930_def.xml EX-101.DEF 127198
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrna-20120930_lab.xml EX-101.LAB 704770
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrna-20120930_pre.xml EX-101.PRE 299551
Mailing Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021
Business Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021 4259083600
Marina Biotech, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 121243747
SIC: 2834 Pharmaceutical Preparations